GeneMind Biosciences
Lei Sun has an extensive background in biosciences and chemistry, currently serving as the Chief Technology Officer at GeneMind Biosciences since December 2018. Prior roles include Head of Chemistry at Element Biosciences and various positions at Pacific Biosciences, where Lei Sun contributed significantly to the development of the SMRT sequencing system, improving sequencing throughput and assay development. Previous experience encompasses leadership in nanoparticle research at Intel, DNA biochip fabrication at Motorola, and R&D at Amersham Biosciences, emphasized by a strong educational foundation with a Master's degree in Chemistry from Case Western Reserve University and a Bachelor's degree in Material Science from the University of Science and Technology of China.
This person is not in any teams
This person is not in any offices
GeneMind Biosciences
Founded in 2012, GeneMind Biosciences is a biotech company located in Shenzhen, China. We are dedicated to developing cutting-edge genome sequencing technologies and tools that can be widely used for every person's healthcare. We believe that genome sequencing is one of the most powerful technologies of the 21st century. By sequencing the millions of individuals, the big data of personal DNA information can bring us closer to curing diseases like cancer and rare genetic diseases, and we can collectively change the world for the better.